Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0140-6736(74)92713-5 | DOI Listing |
Risk Manag Healthc Policy
November 2024
Department of Family Medicine, Samsun University Faculty of Medicine, Samsun, Turkey.
Background: The objective of this study is to compare the measles immunoglobulin G (IgG) and rubella IgG levels in patient groups with mild and severe COVID-19 disease and reveal the possible relationship.
Methods: This study was conducted among COVID-19-confirmed patients over 18, under 65 years of age. This study involved 75 participants- divided into two groups.
BMC Infect Dis
March 2023
Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), Fort Collins, CO, USA.
Background: In yellow fever (YF) endemic areas, measles, mumps, and rubella (MMR), and YF vaccines are often co-administered in childhood vaccination schedules. Because these are live vaccines, we assessed potential immune interference that could result from co-administration.
Methods: We conducted an open-label, randomized non-inferiority trial among healthy 1-year-olds in Misiones Province, Argentina.
JMA J
October 2022
Department of Obstetrics and Gynecology, Japanese Red Cross Katsushika Maternity Hospital, Tokyo, Japan.
Vaccines (Basel)
April 2022
Department of Obstetrics and Gynecology, School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
This study aimed to identify the factors predicting rubella vaccination status based on self-reported data and the presence of sufficient rubella antibody titers in pregnant women in Japan. We used the results of the nationwide questionnaire survey conducted at obstetric facilities in the Pregnant Women Health Initiative Project (PWHI), with 23 participating hospitals recruiting pregnant women from June 2018-November 2019. We extracted age, the number of deliveries, educational level, household income, pre-pregnancy smoking, and knowledge of rubella from questionnaires and medical records.
View Article and Find Full Text PDFVaccines (Basel)
September 2021
Department of Internal Medicine, Hyogo Prefectural Tamba Medical Center, 2002-7 Iso, Hikami-cho, Tamba 669-3495, Japan.
We present an extremely rare case of rubella that developed after rubella vaccine administration. A 54-year-old man complained of back and neck pain for some days. He presented with generalized rash and arthralgia that had persisted for two days before his visit.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!